Therapeutic Group: Others Presentation Rexilo 120: Each tablet contains Relugolix 120 mg. Description Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby, reducing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and consequently testosterone. Indications Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment […]